Abstract
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a potent modulator of pericellular environment through its proteolytic activity and promotes migration, invasion, and proliferation of tumor cells. During cell migration, MT1-MMP binds to CD44H, a major hyaluronan receptor, through the hemopexin-like (HPX) domain and localizes at the migration front. MT1-MMP is also responsible for shedding CD44H, which supports CD44H-mediated cell migration. In this study, we asked whether the binding of MT1-MMP to CD44H is a prerequisite step for the successive shedding. Deletion of the HPX domain deprived MT1-MMP of its shedding activity. Furthermore, disruption of the CD44H/MT1-MMP complex by overexpressing the HPX fragments resulted in inhibition of the shedding. Thus, the CD44H in the complex appears to be the direct substrate of MT1-MMP for shedding. Interestingly, other members of the MT-MMP family showed varied extents of CD44H shedding. Domain swapping between MT1-MMP and other MT-MMPs revealed that the ability of the HPX domains to bind CD44H is conserved among them. However, the shedding activity was different depending on the catalytic domains. The conserved binding ability of the HPX domains suggests that CD44H may act as a core molecule assembling multiple MT-MMPs on the cell surface.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- ADAM:
-
a disintegrin and metalloproteinase
- MT-MMP:
-
membrane-type matrix metalloproteinase
- PMA:
-
phorbol 12-myristate 13-acetate
References
Abecassis I, Olofsson B, Schmid M, Zalcman G and Karniguian A . (2003). Exp. Cell Res., 291, 363–376.
Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ and Cardiff RD . (1998). J. Cell. Physiol., 176, 206–215.
Egeblad M and Werb Z . (2002). Nat. Rev. Cancer, 2, 161–174.
Goebeler M, Kaufmann D, Brocker EB and Klein CE . (1996). J. Cell Sci., 109, 1957–1964.
Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M and Yu DY . (2001). Cancer Res., 61, 984–990.
Ho SN, Hunt HD, Horton RM, Pullen JK and Pease LR . (1989). Gene, 77, 51–59.
Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW and Weiss SJ . (2003). Cell, 114, 33–45.
Itoh Y, Kajita M, Kinoh H, Mori H, Okada A and Seiki M . (1999). J. Biol. Chem., 274, 34260–34266.
Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T and Seiki M . (2001). EMBO J., 20, 4782–4793.
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H and Seiki M . (2001). J. Cell Biol., 153, 893–904.
Kojima S, Itoh Y, Matsumoto S, Masuho Y and Seiki M . (2000). FEBS Lett., 480, 142–146.
Massova I, Kotra LP, Fridman R and Mobashery S . (1998). FASEB J., 12, 1075–1095.
Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I and Seiki M . (2002). EMBO J., 21, 3949–3959.
Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, Yanagida T and Miyasaka M . (2003). J. Biol. Chem., 279, 4541–4550.
Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M and Saya H . (2004). J. Cell Biol., 165, 893–902.
Nakamura H, Suenaga N, Taniwaki K, Matsuki H, Yonezawa K, Fujii M, Okada Y and Seiki M . (2004). Cancer Res., 64, 876–882.
Naot D, Sionov RV and Ish-Shalom D . (1997). Adv. Cancer Res., 71, 241–319.
Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A, Matsumoto M, Ushio Y, Saya H and Wong AJ . (2002). Am. J. Pathol., 160, 441–447.
Ponta H, Sherman L and Herrlich PA . (2003). Nat. Rev. Mol. Cell Biol., 4, 33–45.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M . (1994). Nature, 370, 61–65.
Seiki M, Koshikawa N and Yana I . (2003). Cancer Metast. Rev., 22, 129–143.
Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H and Seiki M . (1996). Cancer Res., 56, 5678–5683.
Ueda J, Kajita M, Suenaga N, Fujii K and Seiki M . (2003). Oncogene, 22, 8716–8722.
Vivinus-Nebot M, Rousselle P, Breittmayer JP, Cenciarini C, Berrih-Aknin S, Spong S, Nokelainen P, Cottrez F, Marinkovich MP and Bernard A . (2004). J. Immunol., 172, 1397–1406.
Yu Q and Stamenkovic I . (1999). Genes Dev., 13, 35–48.
Yu Q and Stamenkovic I . (2000). Genes Dev., 14, 163–176.
Yu WH, Woessner Jr JF, McNeish JD and Stamenkovic I . (2002). Genes Dev., 16, 307–323.
Acknowledgements
We are grateful to Drs Masahiro Kajita, Ikuo Yana, and Naohiko Koshikawa for valuable discussion and Dr Richard Evans for editing the manuscript. This work was supported by the Special Coordination Fund for promoting Science and Technology from the Ministry of Science and Technology of Japan and by a grant-in-aid for Cancer Research from the Ministry of Education, Science and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suenaga, N., Mori, H., Itoh, Y. et al. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 24, 859–868 (2005). https://doi.org/10.1038/sj.onc.1208258
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208258
Keywords
This article is cited by
-
De novo disruptive heterozygous MMP21 variants are potential predisposing genetic risk factors in Chinese Han heterotaxy children
Human Genomics (2022)
-
CD44a functions as a regulator of p53 signaling, apoptosis and autophagy in the antibacterial immune response
Communications Biology (2022)
-
CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion
BMC Cancer (2013)
-
Acidic extracellular microenvironment and cancer
Cancer Cell International (2013)
-
MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
Cancer Cell International (2013)